InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Pierce Robert Hamilton, Dirigeant. Officer active across 1 companies, notably Sensei Biotherapeutics, Inc.. In total, 6 disclosures have been published. Total volume traded: €278k. The latest transaction was filed on 15 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
021,000 shares0
Common Stock
SEC:0001209191-22-010982:0·
021,000 shares0
Common Stock
SEC:0001209191-22-010982·
€100,25516,030 shares@ €6.25420.37% mcap72.1% of flow
Common Stock
SEC:0001209191-21-051172·
€100,25516,030 shares@ €6.25420.37% mcap36.0% of flow
Common Stock
SEC:0001209191-21-051172:0·
€38,8216,460 shares@ €6.00950.14% mcap27.9% of flow
Common Stock
SEC:0001209191-21-050659·
€38,8216,460 shares@ €6.00950.14% mcap14.0% of flow
Common Stock
SEC:0001209191-21-050659:0·
6 of 6 declarations
About Pierce Robert Hamilton
Robert Hamilton Pierce is the Chief Scientific Officer and Chief R&D Officer at Sensei Biotherapeutics, Inc. He is responsible for leading research and innovation efforts. Robert plays a key role in developing new therapies to address medical needs.
